Journal article

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care

Joshua ML Casan, Alison Barraclough, Jake Shortt, Eliza A Hawkes

The Lancet Haematology | ELSEVIER SCI LTD | Published : 2019

DOI: 10.1016/S2352-3026(19)30013-4

Citation metrics

1Dimensions

Keywords

Rituximab
Humans
Science & Technology
Cyclophosphamide
Vincristine
Lymphoma, Large B-Cell, Diffuse
Prospective Studies
Life Sciences & Biomedicine
Etoposide
Prednisone
Standard of Care
Multicenter
Doxorubicin
Hematology
Antineoplastic Combined Chemotherapy Protocols